Latest Breaking News On - Receipt administration - Page 1 : comparemela.com

Phaxiam Therapeutics S A : PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market

Phaxiam Therapeutics S A : PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalNew yorkUnited statesUnited kingdomPharma bioArthur rouillEnregistrement universelEric soyerStefan klotterCompany securitiesReceipt administrationExchange commissionSecurities exchangeCompany annual report on formAmerican depositary sharesNasdaq capital market

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market

Lyon and Cambridge , March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics , a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today.

France generalUnited statesUnited kingdomNew yorkEric soyerPharma bioEnregistrement universelArthur rouillCompany annual report on formAdss for the companySecurities exchangeCompany securitiesExchange commissionReceipt administrationAmerican depositary sharesNasdaq capital market

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market - PHAXIAM Therapeutics (NASDAQ:PHXM)

Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant

France generalUnited statesUnited kingdomNew yorkPharma bioEnregistrement universelReceipt administrationExchange commissionCompany annual report on formSecurities exchangeCompany securitiesAdss for the companyAmerican depositary sharesNasdaq capital marketSecurities exchange actExchange act

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketPHAXIAM remains listed on Eu.

France generalUnited kingdomUnited statesNew yorkArthur rouillPharma bioEnregistrement universelPherecydes pharmaEric soyerCompany annual report on formNasdaq stock market of the companyCompany adssCompany securitiesSecurities exchangeReceipt administrationExchange commission

Investegate | Company Announcement

Investegate announcements from PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

United kingdomFrance generalUnited statesNew yorkEric soyerPherecydes pharmaPharma bioEnregistrement universelArthur rouillCompany securitiesCompany adssExchange commissionNasdaq stock market of the companySecurities exchangeAdss for the companyCompany annual report on form